tiprankstipranks
Advertisement
Advertisement

INM Stock Latest News

InMed Highlights INM-901 Alzheimer’s Data in Q3 Update
Company AnnouncementsInMed Highlights INM-901 Alzheimer’s Data in Q3 Update
3d ago
8K
INM
InMed Pharmaceuticals Reprices Investment Options to Attract Capital
PremiumCompany Announcements
InMed Pharmaceuticals Reprices Investment Options to Attract Capital
13d ago
8K
INM
InMed Pharmaceuticals Announces ATM Offering Prospectus Filing
PremiumCompany Announcements
InMed Pharmaceuticals Announces ATM Offering Prospectus Filing
1M ago
8K
INM
InMed Pharmaceuticals Faces Nasdaq Minimum Bid Price Noncompliance
PremiumCompany Announcements
InMed Pharmaceuticals Faces Nasdaq Minimum Bid Price Noncompliance
1M ago
8K
INM
InMed receives Nasdaq notification regarding minimum bid price compliance
PremiumThe Fly
InMed receives Nasdaq notification regarding minimum bid price compliance
1M ago
INM
InMed warned by Nasdaq over minimum bid price non-compliance
PremiumCompany AnnouncementsInMed warned by Nasdaq over minimum bid price non-compliance
1M ago
INM
InMed Reports Positive Preclinical Data for Alzheimer’s Candidate
Premium
Company Announcements
InMed Reports Positive Preclinical Data for Alzheimer’s Candidate
2M ago
8K
INM
InMed Pharmaceuticals announces preclinical data on effects of INM-901
Premium
The Fly
InMed Pharmaceuticals announces preclinical data on effects of INM-901
2M ago
INM
InMed Pharmaceuticals files $50M mixed securities shelf
PremiumThe Fly
InMed Pharmaceuticals files $50M mixed securities shelf
2M ago
INM
InMed outlines 2026 development plans for lead programs
PremiumCompany Announcements
InMed outlines 2026 development plans for lead programs
2M ago
8K
INM
InMed Pharmaceuticals provides development outlook for 2026
PremiumThe Fly
InMed Pharmaceuticals provides development outlook for 2026
2M ago
INM
InMed Pharmaceuticals Exits BayMedica to Refocus on Pipeline
PremiumCompany Announcements
InMed Pharmaceuticals Exits BayMedica to Refocus on Pipeline
2M ago
8K
INM
InMed Highlights Q2 Results Amid Cash, Regulatory Pressures
PremiumCompany AnnouncementsInMed Highlights Q2 Results Amid Cash, Regulatory Pressures
3M ago
8K
INM
InMed Shareholders Approve Directors and Equity Financing Flexibility
Premium
Company Announcements
InMed Shareholders Approve Directors and Equity Financing Flexibility
5M ago
8K
INM
InMed Faces Challenges from New U.S. Legislation
Premium
Company Announcements
InMed Faces Challenges from New U.S. Legislation
5M ago
8K
INM
InMed Pharmaceuticals Completes Key Study for INM-901
PremiumCompany Announcements
InMed Pharmaceuticals Completes Key Study for INM-901
6M ago
8K
INM
InMed announces completion of pharmacokinetic studies for Alzheimer’s candidate
PremiumThe Fly
InMed announces completion of pharmacokinetic studies for Alzheimer’s candidate
6M ago
INM
InMed Completes Key Pharmacokinetic Studies for Alzheimer’s Candidate INM-901
PremiumCompany Announcements
InMed Completes Key Pharmacokinetic Studies for Alzheimer’s Candidate INM-901
6M ago
INM
InMed Pharmaceuticals Reports Q3 2025 Financial Results
PremiumCompany Announcements
InMed Pharmaceuticals Reports Q3 2025 Financial Results
6M ago
INM
InMed Pharmaceuticals Advances Alzheimer’s Program Amidst Strong Fiscal Start
PremiumCompany AnnouncementsInMed Pharmaceuticals Advances Alzheimer’s Program Amidst Strong Fiscal Start
6M ago
INM
InMed Pharmaceuticals Strengthens Board with Strategic Appointment
Premium
Company Announcements
InMed Pharmaceuticals Strengthens Board with Strategic Appointment
7M ago
INM
InMed Pharmaceuticals Strengthens Board with Appointment of Industry Veteran Neil Klompas
Premium
Company Announcements
InMed Pharmaceuticals Strengthens Board with Appointment of Industry Veteran Neil Klompas
7M ago
INM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >